Tanvex CDMO

Tanvex CDMO is now BORA BIOLOGICS. Please follow our new LinkedIn page to stay connected: https://lnkd.in/guWP4qCH

????

We’re thrilled to announce a significant milestone in our journey to become a CDMO powerhouse! Tanvex has successfully acquired Bora Biologics, a subsidiary of Bora Pharmaceuticals. This union combines Tanvex’s proven expertise in biosimilar development and FDA-approved commercial-scale manufacturing with Bora Biologics strength in early-stage CDMO capabilities. Together, as Bora Biologics, we are redefining CDMO development with seamless, end-to-end solutions designed to accelerate timelines and optimize costs for biopharma companies globally. With this strategic collaboration, we are now uniquely positioned to: + Deliver integrated services, from early-stage development in Taiwan to late-stage and commercial manufacturing in San Diego, USA. + Maintain the highest quality standards through FDA-approved, GMP-compliant processes. ? This merger allows us to better serve your biologics CDMO needs with enhanced capabilities, tailored solutions, and a steadfast commitment to quality and commercialization. To explore this exciting development and what it means for you, we invite you to read our full announcement here: https://lnkd.in/gYXqKBUP. #BiologicsDevelopment #CDMO #Innovation #TanvexBioPharma #BoraBiologics #TanvextoBora

Tanvex at JPM Week 2025 We’re thrilled to announce that Tanvex?will be attending the BIO Partnering @ JPM Week, happening January 13–16, 2025, in San Francisco! Join us as we connect with industry leaders to explore innovative solutions and impactful collaborations in the biopharma and CDMO space. Our leadership team, including Steve Lam – Chief Executive Officer & Marc Goemans – Chief Commercial Officer will be on-site, eager to discuss how Tanvex can support your biologics development and manufacturing needs. Let’s work together to make biologics more accessible for patients worldwide! Schedule a Meeting: https://lnkd.in/gyPHPkit We look forward to seeing you there! #JPWeek2025 #BIOPartnering #TanvexBioPharma #CDMO #BiopharmaInnovation

Happy Holidays from Tanvex CDMO! As we reflect on the past year, we are grateful for our dedicated team, valued partners, and the incredible progress we've made together in advancing biopharmaceutical solutions. Wishing you a joyful and restful holiday season filled with warmth, happiness, and success. Here’s to a prosperous New Year ahead! #HappyHolidays #TanvexCDMO #Biopharmaceuticals #Teamwork #Innovation

We are proud to announce the publication of our Analytical team’s recent article, "Scaling Analytical RP-HPLC to Semi-Preparative for Fractionation and Characterization of Pegfilgrastim Oxidized Variants," in the Journal of Pharmaceutical and Biomedical Analysis. This study, led by our team members - Haley Sutton, Teresa Youngberg, Christian Perez, Anke Hartung, Xuemei Han, and Navin Rauniyar – demonstrates the successful scaling of reversed-phase HPLC to isolate and characterize oxidized variants of pegfilgrastim. Key highlights of the study include: ?? Optimization of semi-preparative chromatography to align with analytical profiles. ?? Application of advanced mass spectrometry techniques to identify oxidation sites. ?? Assessment of the impact of site-specific oxidation on pegfilgrastim's functional activity. These findings underscore the critical role of robust analytical strategies in ensuring the safety and efficacy of biotherapeutic products. Read the full article here: https://lnkd.in/gJ_Pb4hF #Biotechnology #Pharmaceuticals #RP-HPLC #Pegfilgrastim #ResearchInnovation #TeamSuccess #TanvexCDMO

As we gather with family and friends this Thanksgiving, we want to extend our heartfelt gratitude to our incredible team, partners, and clients. Your unwavering support and collaboration are vital to our success. At Tanvex CDMO, we are thankful for the chance to work on innovative biologics projects that make a real difference in people's lives. Our dedicated team consistently brings creativity and expertise to the table, and we appreciate our clients for placing their trust in us with their drug development goals. This Thanksgiving, we also want to honor the patients who benefit from the therapies we help create. Your health motivates us to pursue excellence in all that we do. Wishing you a wonderful Thanksgiving from all of us at Tanvex CDMO! #tanvexCDMO #celltherapy #manufacturing #celltherapymanufacturing #cellandgenetherapy #pharma #pharmaindustry #pharmaceutical #pharmaceuticalindustry #cdmo #contractmanufacturing #biologics #biosimilars #sandiego #thanksgiving #happythanksgiving #november #fall #holidays

Partner with Tanvex CDMO for Expert GMP Manufacturing - In the rapidly evolving biopharma market, Tanvex CDMO bridges the gap between innovative therapies and real-world applications. With FDA-inspected mammalian and microbial GMP manufacturing capabilities, we provide end-to-end support for your biologic programs. Learn More: https://lnkd.in/g76t9mhy #gmp #microbial #mammalian #biopharma #manufacturing #CDMO #biologics

Comprehensive Quality Control at Tanvex CDMO At Tanvex CDMO, we offer a robust testing framework that aligns with global regulatory standards. From raw material testing to final product release assessments, we ensure quality within every step of the way. Our team works closely with regulatory agencies, such as the FDA, to provide best-in-class testing services for your biopharmaceutical products. Learn More: https://lnkd.in/eS_6XqSQ #CDMO #qualityassurance #qualitycontrol #GMP #contractdevelopment #contractmanufacturing #biologics #regulatory

GMP Manufacturing in San Diego: State-of-the-Art Facilities Our San Diego-based GMP manufacturing suites feature advanced technologies for both mammalian and microbial production. From single-use bioreactors to large-scale fermentation, we are equipped to handle a wide range of production needs. Learn More: https://lnkd.in/g76t9mhy #sandeigo #CDMO #GMP #manufacturing #Contractmanufacturing #microbial #mammalian #biologics #biotech #bioreactors